OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Showing 20 citing articles:

Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 79

VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 42

Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma
Yang Liu, Jiawen Wu, Huiqin Hao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

Hybrid lipid nanoparticles with tumor antigen-primed dendritic cell membranes for post-surgical tumor immunotherapy
Dongyoon Kim, Jiwon Choi, D-H Jin, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 537-548
Closed Access

Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access

Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 166-166
Open Access

Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 4

Tug of War: Understanding the Dynamic Interplay of Tumor Biomechanical Environment on Dendritic Cell Function
Brian Chesney Quartey, Gabriella Torres, Mei ElGindi, et al.
Mechanobiology in Medicine (2024) Vol. 2, Iss. 3, pp. 100068-100068
Open Access | Times Cited: 2

Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Hybrid nanoparticle–mediated simultaneous ROS scavenging and STING activation improve the antitumor immunity of in situ vaccines
Jianing Li, Tianze Wu, Weidong Wang, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 2

Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
Lubna Noor, Arun Upadhyay, Vibhuti Joshi
Biology (2024) Vol. 13, Iss. 10, pp. 846-846
Open Access | Times Cited: 2

Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
Jiřina Bartůňková
Onco (2024) Vol. 4, Iss. 1, pp. 46-55
Open Access | Times Cited: 1

Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting
Dario Troise, Barbara Infante, Silvia Mercuri, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 1

KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma
Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 10, pp. 1378-1388
Closed Access | Times Cited: 1

Dendritic Cell-Targeted Nanoparticles Enhance T Cell Activation and Antitumor Immune Responses by Boosting Antigen Presentation and Blocking PD-L1 Pathways
Prateek Srivastava, Marie Rütter, Gover Antoniraj, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 1

Unlocking Dendritic Cell-Based Vaccine Efficacy through Genetic Modulation—How Soon Is Now?
Ahmed Elwakeel, Hannah E. Bridgewater, Jason Bennett
Genes (2023) Vol. 14, Iss. 12, pp. 2118-2118
Open Access | Times Cited: 4

Present and Future of Immunotherapy for Triple-Negative Breast Cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers, et al.
(2024)
Open Access

Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis
Kirstie Wong Chee Ching, Noor Fatmawati Mokhtar, Gee Jun Tye
Computers in Biology and Medicine (2024) Vol. 184, pp. 109396-109396
Closed Access

Akkermansia muciniphila- and Pathogenic Bacteria-Derived Endotoxins Differently Regulate Human Dendritic Cell Generation and γδ T Lymphocyte Activation
Veronica Fertitta, Barbara Varano, Manuela Del Cornò, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1571-1571
Open Access

Page 1

Scroll to top